Carregando...
Dornase alfa for cystic fibrosis
BACKGROUND: Dornase alfa is currently used as a mucolytic to treat pulmonary disease (the major cause of morbidity and mortality) in cystic fibrosis. It reduces mucus viscosity in the lungs, promoting improved clearance of secretions. This is an update of a previously published review. OBJECTIVES: T...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2018
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513278/ https://ncbi.nlm.nih.gov/pubmed/30187450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001127.pub4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|